These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3980333)

  • 1. The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitis.
    Scheld WM; Tauber MG; Zak O; Sande MA
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():303-12. PubMed ID: 3980333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of antibiotics in experimental bacterial meningitis--two sides to rapid bacterial killing in the cerebrospinal fluid.
    Täuber MG; Sande MA
    Scand J Infect Dis Suppl; 1990; 74():173-8. PubMed ID: 2097706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General principles of therapy of pyogenic meningitis.
    Täuber MG; Sande MA
    Infect Dis Clin North Am; 1990 Dec; 4(4):661-76. PubMed ID: 2277194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and bacteriological correlations between antimicrobial therapy of experimental meningitis in rabbits and meningitis in humans: a review.
    McCracken GH
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():97-108. PubMed ID: 6365874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles in the treatment of bacterial meningitis.
    Täuber MG; Sande MA
    Am J Med; 1984 May; 76(5A):224-30. PubMed ID: 6372474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations.
    Schmidt T; Täuber MG
    J Antimicrob Chemother; 1993 May; 31 Suppl D():61-70. PubMed ID: 8335525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antibiotic efficacy in acute bacterial meningitis.
    Beam TR; Allen JC
    Clin Pharmacol Ther; 1979 Feb; 25(2):199-203. PubMed ID: 759073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts of bacterial infections of the central nervous system. Bacterial meningitis and bacterial brain abscess.
    Garvey G
    J Neurosurg; 1983 Nov; 59(5):735-44. PubMed ID: 6352873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.
    Scheld WM
    Eur J Clin Microbiol; 1984 Dec; 3(6):579-91. PubMed ID: 6396094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.
    Täuber MG; Doroshow CA; Hackbarth CJ; Rusnak MG; Drake TA; Sande MA
    J Infect Dis; 1984 Apr; 149(4):568-74. PubMed ID: 6327835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of mannitol on the penetration of teicoplanin into infected CSF of experimental Staphylococcus aureus meningitis of rabbits.
    Manquat G; Stahl JP; Pelloux I; Micoud M
    Infection; 1990; 18(2):113-6. PubMed ID: 2139637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM; Rocha H; Sande MA; Bryan JP
    Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriologic and pharmacodynamic basis for treating bacterial meningitis (author's transl)].
    Armengaud M
    Sem Hop; 1982 Feb; 58(5):268-74. PubMed ID: 6277005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic pharmacodynamics in cerebrospinal fluid.
    Lutsar I; McCracken GH; Friedland IR
    Clin Infect Dis; 1998 Nov; 27(5):1117-27, quiz 1128-9. PubMed ID: 9827256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus.
    Scheld WM; Keeley JM; Field MR; Brodeur JP
    J Antimicrob Chemother; 1987 May; 19(5):647-58. PubMed ID: 3497147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily gentamicin therapy for experimental Escherichia coli meningitis.
    Ahmed A; París MM; Trujillo M; Hickey SM; Wubbel L; Shelton SL; McCracken GH
    Antimicrob Agents Chemother; 1997 Jan; 41(1):49-53. PubMed ID: 8980753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Permeability of antibacterial drugs in the cerebrospinal fluid].
    Meyer FP; Walther H
    Z Arztl Fortbild (Jena); 1984; 78(17):703-10. PubMed ID: 6506776
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of antimicrobial drugs in the cerebrospinal fluid.
    Skopnik H; Heimann G
    Pediatr Pharmacol (New York); 1983; 3(3-4):313-20. PubMed ID: 6330656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid.
    Lutsar I; Friedland IR
    Clin Pharmacokinet; 2000 Nov; 39(5):335-43. PubMed ID: 11108433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.